Contribution of microRNA 24-3p and Erk1/2 to interleukin-6-mediated plasma cell survival

European Journal of Immunology

Volumn 43, Issue 11, 2013, Pages 3028-3037

  Gabler, Jessica ^a,c   Wittmann, Jürgen ^b   Porstner, Martina ^b   Renz, Harald ^a   Jäck, Hans Martin ^b   Abram, Melanie ^a   Zemlin, Michael ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Erk1 2; Interleukin 6; MicroRNA 24 3p; Plasma cells; Survival

Indexed keywords

INTERLEUKIN 6; MICRORNA 24; MICRORNA 24 3P; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; STROMAL CELL DERIVED FACTOR 1ALPHA; UNCLASSIFIED DRUG;

ALLERGIC DISEASE; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL SURVIVAL; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; MULTIPLE MYELOMA; PLASMA CELL; PLASMACYTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL FACTOR; UPREGULATION;

ERK1/2; INTERLEUKIN-6; MICRORNA-24-3P; PLASMA CELLS; SURVIVAL;

B-LYMPHOCYTES; BASE SEQUENCE; CELL LINE, TUMOR; CELL SURVIVAL; CELLULAR MICROENVIRONMENT; CHEMOKINE CXCL12; ENDOPLASMIC RETICULUM STRESS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-6; MICRORNAS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MULTIPLE MYELOMA; PLASMA CELLS; PLASMACYTOMA; SEQUENCE ANALYSIS, DNA; UP-REGULATION;

EID: 84888029826     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201243271     Document Type: Article

References (47)

1. Fairfax, K. A., Kallies, A., Nutt, S. L. and Tarlinton, D. M., Plasma cell development: from B-cell subsets to long-term survival niches. Semin. Immunol. 2008. 20: 49-58.
2. Ho, F., Lortan, J. E., MacLennan, I. C. and Khan, M., Distinct short-lived and long-lived antibody-producing cell populations. Eur. J. Immunol. 1986. 16: 1297-1301.
3. Slifka, M. K., Antia, R., Whitmire, J. K. and Ahmed, R., Humoral immunity due to long-lived plasma cells. Immunity 1998. 8: 363-372.
4. Minges Wols, H. A., Ippolito, J. A., Yu, Z., Palmer, J. L., White, F. A., Le, P. T. and Witte, P. L., The effects of microenvironment and internal programming on plasma cell survival. Int. Immunol. 2007. 19: 837-846.
5. Hoyer, B. F., Moser, K., Hauser, A. E., Peddinghaus, A., Voigt, C., Eilat, D., Radbruch, A. et al., Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB/W mice. J. Exp. Med. 2004. 199: 1577-1584.
6. Mesin, L., Di Niro, R., Thompson, K. M., Lundin, K. E. and Sollid, L. M., Long-lived plasma cells from human small intestine biopsies secrete immunoglobulins for many weeks in vitro. J. Immunol. 2011. 187: 2867-2874.
7. Rodriguez Gomez, M., Talke, Y., Goebel, N., Hermann, F., Reich, B. and Mack, M., Basophils support the survival of plasma cells in mice. J. Immunol. 2010. 185: 7180-7185.
8. Chu, V. T. and Berek, C., Immunization induces activation of bone marrow eosinophils required for plasma cell survival. Eur. J. Immunol. 2012. 42: 130-137.
9. Radbruch, A., Muehlinghaus, G., Luger, E. O., Inamine, A., Smith, K. G., Dorner, T. and Hiepe, F., Competence and competition: the challenge of becoming a long-lived plasma cell. Nat. Rev. Immunol. 2006. 6: 741-750.
10. Shapiro-Shelef, M., Lin, K. I., Savitsky, D., Liao, J. and Calame, K., Blimp-1 is required for maintenance of long-lived plasma cells in the bone marrow. J. Exp. Med. 2005. 202: 1471-1476.
11. Shaffer, A. L., Shapiro-Shelef, M., Iwakoshi, N. N., Lee, A. H., Qian, S. B., Zhao, H., Yu, X. et al., XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation. Immunity 2004. 21: 81-93.
12. Chopin, M., Chacón-Martínez, C. A. and Jessberger, R., Fine tuning of IRF-4 expression by SWAP-70 controls the initiation of plasma cell development. Eur. J. Immunol. 2011. 41: 3063-3074.
13. Alinikula, J., Nera, K. P., Junttila, S. and Lassila, O., Alternate pathways for Bcl6-mediated regulation of B cell to plasma cell differentiation. Eur. J. Immunol. 2011. 41: 2404-2413.
14. Filipowicz, W., Bhattacharyya, S. N. and Sonenberg, N., Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat. Rev. Genet. 2008. 9: 102-114.
15. Baltimore, D., Boldin, M. P., O'Connell, R. M., Rao, D. S. and Taganov, K. D., MicroRNAs: new regulators of immune cell development and function. Nat. Immunol. 2008. 9: 839-845.
16. Vigorito, E., Perks, K. L., Abreu-Goodger, C., Bunting, S., Xiang, Z., Kohlhaas, S., Das, P. P. et al, microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity 2007. 27: 847-859.
17. Wang, Q., Huang, Z., Xue, H., Jin, C., Ju, X. L., Han, J. D. J. and Chen, Y. G., MicroRNA miR-24 inhibits erythropoiesis by targeting activin type I receptor ALK4. Blood 2008. 111: 588-595.
18. Lal, A., Pan, Y., Navarro, F., Dykxhoorn, D. M., Moreau, L., Meire, E., Bentwich, Z. et al., miR-24-mediated downregulation of H2AX suppresses DNA repair in terminally differentiated blood cells. Nat. Struct. Mol. Biol. 2009. 16: 492-498.
19. Lal, A., Navarro, F., Maher, C. A., Maliszewski, L. E., Yan, N., O'Day, E., Chowdhury, D. et al., miR-24 inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to. Mol. Cell 2009. 35: 610-625.
20. Mohr, E., Serre, K., Manz, R. A., Cunningham, A. F., Khan, M., Hardie, D. L., Bird, R. et al., Dendritic cells and monocyte/macrophages that create the IL-6/APRIL-rich lymph node microenvironments where plasmablasts mature. J. Immunol. 2009. 182: 2113-2123.
21. Minges Wols, H. A., Underhill, G. H., Kansas, G. S. and Witte, P. L., The role of bone marrow-derived stromal cells in the maintenance of plasma cell longevity. J. Immunol. 2002. 169: 4213-4221.
22. Rozanski, C. H., Arens, R., Carlson, L. M., Nair, J., Boise, L. H., Chanan-Khan, A. A., Schoenberger, S. P. et al., Sustained antibody responses depend on CD28 function in bone marrow-resident plasma cells. J. Exp. Med. 2011. 208: 1435-1446.
23. Giuliani, N., Rizzoli, V. and Roodman, G. D., Multiple myeloma bone disease: pathophysiology of osteoblast inhibition. Blood 2006. 108: 3992-3996.
24. Bommert, K., Bargou, R. C. and Stühmer, T., Signalling and survival pathways in multiple myeloma. Eur. J. Cancer 2006. 42: 1574-1580.
25. Podar, K., Chauhan, D. and Anderson, K., Bone marrow microenvironment and the identification of new targets for myeloma therapy. Leukemia 2008. 23: 10-24.
26. Duda, D. G., Kozin, S. V., Kirkpatrick, N. D., Xu, L., Fukumura, D. and Jain, R. K., CXCL12 (SDF1α)-CXCR4/CXCR7 pathway inhibition: an emerging sensitizer for anticancer therapies? Clin. Cancer Res. 2011. 17: 2074-2080.
27. Xu, S., Menu, E., Becker, A. D., Van Camp, B., Vanderkerken, K. and Van Riet, I., Bone marrow-derived mesenchymal stromal cells are attracted by multiple myeloma cell-produced chemokine CCL25 and favor myeloma cell growth in vitro and in vivo. Stem Cells 2012. 30: 266-279.
28. Todd, D. J., Lee, A. H. and Glimcher, L. H., The endoplasmic reticulum stress response in immunity and autoimmunity. Nat. Rev. Immunol. 2008. 8: 663-674.
29. Brewer, J. W., Hendershot, L. M., Sherr, C. J. and Diehl, J. A., Mammalian unfolded protein response inhibits cyclin D1 translation and cell-cycle progression. Proc. Natl. Acad. Sci. 1999. 96: 8505-8510.
30. Qin, W., Shi, Y., Zhao, B., Yao, C., Jin, L., Ma, J. and Jin, Y., miR-24 regulates apoptosis by targeting the open reading frame (ORF) region of FAF1 in cancer cells. PLoS One 2010. 5: e9429.
31. Walker, J. C. and Harland, R. M., microRNA-24a is required to repress apoptosis in the developing neural retina. Genes Development 2009. 23: 1046-1051.
32. Nguyen, T., Rich, A. and Dahl, R., MiR-24 promotes the survival of hematopoietic cells. PLoS One 2013. 8: e55406.
33. Singh, R. and Saini, N., Downregulation of BCL2 by miRNAs augments drug-induced apoptosis-a combined computational and experimental approach. J. Cell Sci. 2012. 125: 1568-1578.
34. Fiedler, J., Jazbutyte, V., Kirchmaier, B. C., Gupta, S. K., Lorenzen, J., Hartmann, D., Galuppo, P. et al., MicroRNA-24 regulates vascularity after myocardial infarction clinical perspective. Circulation 2011. 124: 720-730.
35. Xie, Y., Tobin, L., Camps, J., Wangsa, D., Yang, J., Rao, M., Witasp, E. et al., MicroRNA-24 regulates XIAP to reduce the apoptosis threshold in cancer cells. Oncogene 2013. 32: 2442-2451.
36. Puthalakath, H., O'Reilly, L. A., Gunn, P., Lee, L., Kelly, P. N., Huntington, N. D., Hughes, P. D. et al., ER stress triggers apoptosis by activating BH3-only protein Bim. Cell 2007. 129: 1337-1349.
37. Ley, R., Ewings, K., Hadfield, K. and Cook, S., Regulatory phosphorylation of Bim: sorting out the ERK from the JNK. Cell Death Differ. 2005. 12: 1008-1014.
38. Qian, L., Van Laake, L. W., Huang, Y., Liu, S., Wendland, M. F. and Srivastava, D., miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes. J. Exp. Med. 2011. 208: 549-560.
39. Podar, K., Hideshima, T., Chauhan, D. and Anderson, K. C., Targeting signalling pathways for the treatment of multiple myeloma. Exp. Opin. Therap. Targets 2005. 9: 359-381.
40. Le Gouill, S., Podar, K., Harousseau, J. L. and Anderson, K. C., Mcl-1 regulation and its role in multiple myeloma. Cell Cycle 2004. 3: 1259-1262.
41. Pichiorri, F., Suh, S. S., Ladetto, M., Kuehl, M., Palumbo, T., Drandi, D., Taccioli, C. et al., MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. Proc. Natl. Acad. Sci. 2008. 105: 12885-12890.
42. Hideshima, T., Mitsiades, C., Tonon, G., Richardson, P. G. and Anderson, K. C., Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets. Nat. Rev. Cancer 2007. 7: 585-598.
43. Feng, J., Iwama, A., Satake, M. and Kohu, K., MicroRNA-27 enhances differentiation of myeloblasts into granulocytes by post-transcriptionally downregulating Runx1. Brit. J. Haematol. 2009. 145: 412-423.
44. Paroo, Z., Ye, X., Chen, S. and Liu, Q., Phosphorylation of the human microRNA-generating complex mediates MAPK/Erk signaling. Cell 2009. 139: 112-122.
45. Bird, J., Owen, R., D'Sa, S., Snowden, J., Pratt, G. and Ashcroft, J., On behalf of the Haemato-oncology Task Force of British Committee for Standards in Haematology (BCSH) and UK Myeloma Forum. Guidelines for the diagnosis and management of multiple myeloma 2011. Brit. J. Haematol. 2011. 154: 32-75.
46. Würflein, D., Dechant, M., Stockmeyer, B., Tutt, A. L., Hu, P., Repp, R., Kalden, J. R. et al., Evaluating antibodies for their capacity to induce cell-mediated lysis of malignant B cells. Cancer Res. 1998. 58: 3051-3058.
47. Hackenberg, M., Sturm, M., Langenberger, D., Falcon-Perez, J. M. and Aransay, A. M., miRanalyzer: a microRNA detection and analysis tool for next-generation sequencing experiments. Nucl. Acids Res. 2009. 37: W68-W76.